These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30220937)

  • 1. Bottom Up Ethics - Neuroenhancement in Education and Employment.
    Bard I; Gaskell G; Allansdottir A; da Cunha RV; Eduard P; Hampel J; Hildt E; Hofmaier C; Kronberger N; Laursen S; Meijknecht A; Nordal S; Quintanilha A; Revuelta G; Saladié N; Sándor J; Santos JB; Seyringer S; Singh I; Somsen H; Toonders W; Torgersen H; Torre V; Varju M; Zwart H
    Neuroethics; 2018; 11(3):309-322. PubMed ID: 30220937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The is and ought of the Ethics of Neuroenhancement: Mind the Gap.
    Forlini C; Hall W
    Front Psychol; 2015; 6():1998. PubMed ID: 26779100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.
    Schleim S; Quednow BB
    Front Pharmacol; 2018; 9():3. PubMed ID: 29403383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On pharmacological neuroenhancement as part of the new neurorights' pioneering legislation in Chile: a perspective.
    Cornejo-Plaza MI; Saracini C
    Front Psychol; 2023; 14():1177720. PubMed ID: 37533709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smart drugs "as common as coffee": media hype about neuroenhancement.
    Partridge BJ; Bell SK; Lucke JC; Yeates S; Hall WD
    PLoS One; 2011; 6(11):e28416. PubMed ID: 22140584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hacking the Brain: Dimensions of Cognitive Enhancement.
    Dresler M; Sandberg A; Bublitz C; Ohla K; Trenado C; Mroczko-Wąsowicz A; Kühn S; Repantis D
    ACS Chem Neurosci; 2019 Mar; 10(3):1137-1148. PubMed ID: 30550256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public Views on Whether the Use of Pharmaceutical Neuroenhancements Should Be Allowed.
    Hendriks S; Li X; Grady C; Kim SY
    Neurology; 2024 Aug; 103(4):e209681. PubMed ID: 39042847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender Norms and Gender Equality in Full-Time Employment and Health: A 97-Country Analysis of the World Values Survey.
    Cislaghi B; Bhatia A; Hallgren EST; Horanieh N; Weber AM; Darmstadt GL
    Front Psychol; 2022; 13():689815. PubMed ID: 35769749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.
    Graf WD; Nagel SK; Epstein LG; Miller G; Nass R; Larriviere D
    Neurology; 2013 Mar; 80(13):1251-60. PubMed ID: 23486879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cross-Sectional Study of Attitudes toward Willingness to Use Enhancement Technologies: Implications for Technology Regulation and Ethics.
    Nakazawa E; Mori K; Udagawa M; Akabayashi A
    BioTech (Basel); 2022 Jun; 11(3):. PubMed ID: 35892926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The way forward for neuroethics in Japan: A review of five topics surrounding present challenges.
    Nakazawa E; Fukushi T; Tachibana K; Uehara R; Arie F; Akter N; Maruyama M; Morita K; Araki T; Sadato N
    Neurosci Res; 2022 Oct; 183():7-16. PubMed ID: 35882301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Neuroenhancement in the Field of Economics-Poll Results from an Online Survey.
    Dietz P; Soyka M; Franke AG
    Front Psychol; 2016; 7():520. PubMed ID: 27148128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroenhancement for sale: assessing the website claims of neurofeedback providers in the United States.
    Wexler A; Nagappan A; Kopyto D; Choi R
    J Cogn Enhanc; 2020 Dec; 4(4):379-388. PubMed ID: 34164596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Options, limits and ethics of pharmacological neuroenhancement].
    Normann C; Boldt J; Maio G; Berger M
    Nervenarzt; 2010 Jan; 81(1):66-74. PubMed ID: 19851745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive neuroenhancement: false assumptions in the ethical debate.
    Heinz A; Kipke R; Heimann H; Wiesing U
    J Med Ethics; 2012 Jun; 38(6):372-5. PubMed ID: 22228818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students.
    Maier LJ; Liechti ME; Herzig F; Schaub MP
    PLoS One; 2013; 8(11):e77967. PubMed ID: 24236008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and motives for pharmacological neuroenhancement in Switzerland--results from a national Internet panel.
    Maier LJ; Haug S; Schaub MP
    Addiction; 2016 Feb; 111(2):280-95. PubMed ID: 26189457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is diminishment a form of enhancement? Rethinking the enhancement debate in biomedical ethics.
    Earp BD; Sandberg A; Kahane G; Savulescu J
    Front Syst Neurosci; 2014; 8():12. PubMed ID: 24550792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. True and false concerns about neuroenhancement: a response to 'Neuroenhancers, addiction and research ethics', by D M Shaw.
    Heinz A; Kipke R; Müller S; Wiesing U
    J Med Ethics; 2014 Apr; 40(4):286-7. PubMed ID: 23468510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.